---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-113809"
form_type: "8-K"
ticker: "WW"
cik: "0000105319"
company_name: "WW INTERNATIONAL, INC."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T10:36:53.403446+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# WW Q1 revenue down 9.7% to $186.6M; clinical revenue up 57%; in debt restructuring talks

## Summary
- Net loss improved to $72.6M ($0.91 EPS loss) from $347.9M ($4.39) YoY.
- Clinical subscription revenue rose 57.1% to $29.5M; total subscribers fell 14.2% to 3.4M.
- Adjusted EBITDAS surged to $26.9M from $7.2M; gross margin expanded 450 bps to 71.2%.
- Substantive discussions with lenders/noteholders on debt-reduction plan expected imminently.
- Cash and equivalents $236.3M including $171.3M drawn on revolver.

## SEC filing metadata
- accession: 0001193125-25-113809
- form_type: 8-K
- ticker: WW
- cik: 0000105319
- company_name: WW INTERNATIONAL, INC.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105319/000119312525113809/0001193125-25-113809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105319/000119312525113809/d895450d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-113809
- JSON: https://secwatch.observer/filing/0001193125-25-113809.json
- Plain text: https://secwatch.observer/filing/0001193125-25-113809.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.